{
  "docId": "019de071-f36b-702d-acba-b009d415a6aa",
  "docSlug": "7f10ea97b4031d406788e9f98a2cb8e4",
  "documentTitle": "Alkermes | Investor Conference Presentation Deck | 36 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 36,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "segmentation",
  "function": "prioritize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a 3-circle Venn diagram to define the target audience segment.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-f36b-702d-acba-b009d415a6aa/11",
  "deckHref": "/decks/019de071-f36b-702d-acba-b009d415a6aa",
  "deckJsonHref": "/decks/019de071-f36b-702d-acba-b009d415a6aa.json",
  "deckAnchorHref": "/decks/019de071-f36b-702d-acba-b009d415a6aa#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.18,
        "y": 0.23
      },
      "kind": "framework",
      "text": "Venn diagram showing intersection of: Initiates therapy, Prescribes olanzapine, Utilizes branded oral atypical antipsychotic products",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84aa59c5-65f4-4576-8f2a-c3d67eca89e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.64,
        "y": 0.41
      },
      "kind": "paragraph",
      "text": "Alkermes field organization calls on focused healthcare provider universe, prioritized for high-potential prescribers of branded oral antipsychotics",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3994239d-97c1-45b4-92e9-1d4f9eb2c08d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "LYBALVI®: Launch Targeting Focused on Three Prescriber Characteristics Across Schizophrenia and BD-1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d43f009b-7b36-4972-a073-4448323c7bda",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Venn diagram",
      "slug": "venn-diagram",
      "agent": null,
      "layer": "slide",
      "matchId": "37cd4f24-3e17-4580-a2bc-c33920adfb5e",
      "evidence": "The slide explicitly mentions 'Venn diagram showing intersection of: Initiates therapy, Prescribes olanzapine, Utilizes branded oral atypical antipsychotic products'.",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "venn",
      "slug": null,
      "matchId": "6d26c872-2d6a-4a0d-b64c-1feb6364ccfa",
      "evidence": "Three overlapping circles used to define a target segment.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 8,
      "beatId": "3953b8e8-5b64-44bd-871f-3b007b1fcd59",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents LYBALVI as a solution with proven efficacy and a differentiated weight gain profile",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 8,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "882e1a41-7fce-4861-a6c7-7bdfc4115374",
      "evidence": "The deck presents LYBALVI's commercial launch and its potential benefits",
      "position": 1,
      "objective": "Presenting LYBALVI as a quick win with a big bet on its commercial potential",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}